- Home
- SVMH vs PBM Comparison
SVMH vs PBM Comparison
Compare SVMH & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVMH
- PBM
- Stock Information
- Founded
- SVMH 2018
- PBM 1994
- Country
- SVMH Cayman Islands
- PBM Canada
- Employees
- SVMH N/A
- PBM N/A
- Industry
- SVMH
- PBM
- Sector
- SVMH
- PBM
- Exchange
- SVMH Nasdaq
- PBM NYSE
- Market Cap
- SVMH 7.3M
- PBM 7.5M
- IPO Year
- SVMH N/A
- PBM N/A
- Fundamental
- Price
- SVMH $0.86
- PBM $1.79
- Analyst Decision
- SVMH
- PBM
- Analyst Count
- SVMH 0
- PBM 0
- Target Price
- SVMH N/A
- PBM N/A
- AVG Volume (30 Days)
- SVMH 7.8M
- PBM 5.4M
- Earning Date
- SVMH 02-15-2025
- PBM 02-02-2025
- Dividend Yield
- SVMH N/A
- PBM N/A
- EPS Growth
- SVMH N/A
- PBM N/A
- EPS
- SVMH N/A
- PBM N/A
- Revenue
- SVMH $42,538.00
- PBM N/A
- Revenue This Year
- SVMH N/A
- PBM N/A
- Revenue Next Year
- SVMH N/A
- PBM N/A
- P/E Ratio
- SVMH N/A
- PBM N/A
- Revenue Growth
- SVMH N/A
- PBM N/A
- 52 Week Low
- SVMH $0.02
- PBM $1.51
- 52 Week High
- SVMH $1.24
- PBM $593.25
- Technical
- Relative Strength Index (RSI)
- SVMH 78.57
- PBM 39.22
- Support Level
- SVMH $0.65
- PBM $1.61
- Resistance Level
- SVMH $1.23
- PBM $2.25
- Average True Range (ATR)
- SVMH 0.09
- PBM 0.22
- MACD
- SVMH 0.09
- PBM 0.06
- Stochastic Oscillator
- SVMH 68.21
- PBM 23.38
About SVMH SRIVARU Holding Limited
SRIVARU Holding Ltd focuses to revolutionize two-wheeled vehicles (TWV) by developing products powered by renewable energy, which are assured for safety, performance, and comfort, thereby providing safe riding experience to its customers. It operates in one reportable segment which is vehicle manufacturing. SVH's first product line, the Prana, is a E2W vehicle that is redefining the category. SVH has commenced engineering and design work for the Prana-Elite that is expected to leverage the same platform as the Prana-Grand, while upgrading its range.
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.